NF-κB Activator 1 downregulation in macrophages activates STAT3 to promote adenoma-adenocarcinoma transition and immunosuppression in colorectal cancer

Shunyi Wang,Yihe Kuai,Simin Lin,Li Li,Quliang Gu,Xiaohan Zhang,Xiaoming Li,Yajun He,Sishuo Chen,Xiaoru Xia,Zhang Ruan,Caixia Lin,Yi Ding,Qianqian Zhang,Cuiling Qi,Jiangchao Li,Xiaodong He,Janak L. Pathak,Weijie Zhou,Side Liu,Lijing Wang,Lingyun Zheng
DOI: https://doi.org/10.1186/s12916-023-02791-0
IF: 9.3
2023-03-31
BMC Medicine
Abstract:Adenoma-adenocarcinoma transition is a key feature of colorectal cancer (CRC) occurrence and is closely regulated by tumor-associated macrophages (TAMs) and CD8 + T cells. Here, we investigated the effect of the NF-κB activator 1 (Act1) downregulation of macrophages in the adenoma-adenocarcinoma transition.
medicine, general & internal
What problem does this paper attempt to address?